Insider · CIK 0001745938

Taubert Jennifer L

Reports to the SEC for 2 companies · CHICAGO, IL

sec.gov

Transactions

Companies

Filings

CIK

0001745938

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-30	MCDMCDONALDS CORP · Phantom StockA Award	Director	AAward	+129.9 sh	$230.94	+$30K	4,108.7
2026-08-17	JNJJOHNSON & JOHNSONM Exercise/Conversion	EVP, WWC. Innovative Medicine	MExercise/Conversion	+15K sh	$115.67	+$1.74M	209,451.001
2026-08-17	JNJJOHNSON & JOHNSONS Sale	EVP, WWC. Innovative Medicine	SSale	−15K sh	$263.36	−$3.95M	194,451.001
2026-08-17	JNJJOHNSON & JOHNSON · Employee Stock Options (Right to Buy)M Exercise/Conversion	EVP, WWC. Innovative Medicine	MExercise/Conversion	−15K sh	—	—	28,712
2026-06-30	MCDMCDONALDS CORP · Phantom StockA Award	Director	AAward	+110.99 sh	$270.31	+$30K	3,949.25
2026-03-31	MCDMCDONALDS CORP · Phantom StockA Award	Director	AAward	+96.53 sh	$310.79	+$30K	3,813.63
2026-02-15	JNJJOHNSON & JOHNSONM Exercise/Conversion	EVP, WWC. Innovative Medicine	MExercise/Conversion	+1,594 sh	—	—	194,365.001
2026-02-15	JNJJOHNSON & JOHNSONF Tax Payment	EVP, WWC. Innovative Medicine	FTax Payment	−816 sh	$243.45	−$199K	193,549.001
2026-02-15	JNJJOHNSON & JOHNSONM Exercise/Conversion	EVP, WWC. Innovative Medicine	MExercise/Conversion	+1,847 sh	—	—	195,396.001
2026-02-15	JNJJOHNSON & JOHNSONF Tax Payment	EVP, WWC. Innovative Medicine	FTax Payment	−945 sh	$243.45	−$230K	194,451.001
2026-02-15	JNJJOHNSON & JOHNSON · Restricted Share UnitsM Exercise/Conversion	EVP, WWC. Innovative Medicine	MExercise/Conversion	−1,594 sh	—	—	1,594
2026-02-15	JNJJOHNSON & JOHNSON · Restricted Share UnitsM Exercise/Conversion	EVP, WWC. Innovative Medicine	MExercise/Conversion	−1,847 sh	—	—	3,692
2026-02-15	JNJJOHNSON & JOHNSON · Employee Stock Options (Right to Buy)A Award	EVP, WWC. Innovative Medicine	AAward	+54.9K sh	—	—	54,869
2026-02-15	JNJJOHNSON & JOHNSON · Restricted Share UnitsA Award	EVP, WWC. Innovative Medicine	AAward	+3,940 sh	—	—	3,940
2026-02-13	JNJJOHNSON & JOHNSONM Exercise/Conversion	EVP, WWC. Innovative Medicine	MExercise/Conversion	+1,302 sh	—	—	179,315.001
2026-02-13	JNJJOHNSON & JOHNSONF Tax Payment	EVP, WWC. Innovative Medicine	FTax Payment	−409 sh	$244.55	−$100K	178,906.001
2026-02-13	JNJJOHNSON & JOHNSONM Exercise/Conversion	EVP, WWC. Innovative Medicine	MExercise/Conversion	+27.4K sh	—	—	206,318.001
2026-02-13	JNJJOHNSON & JOHNSONF Tax Payment	EVP, WWC. Innovative Medicine	FTax Payment	−13.5K sh	$244.55	−$3.31M	192,771.001
2026-02-13	JNJJOHNSON & JOHNSON · Restricted Share UnitsM Exercise/Conversion	EVP, WWC. Innovative Medicine	MExercise/Conversion	−1,302 sh	—	—	0
2026-02-13	JNJJOHNSON & JOHNSON · Performance Share UnitsM Exercise/Conversion	EVP, WWC. Innovative Medicine	MExercise/Conversion	−27.4K sh	—	—	0
2026-02-09	JNJJOHNSON & JOHNSON · Performance Share UnitsA Award	EVP, WWC. Innovative Medicine	AAward	+27.4K sh	—	—	27,412
2025-12-31	MCDMCDONALDS CORP · Phantom StockA Award	Director	AAward	+768.9 sh	$305.63	+$235K	3,696.03
2025-09-30	MCDMCDONALDS CORP · Phantom StockA Award	Director	AAward	+98.72 sh	$303.89	+$30K	2,910.15
2025-09-04	JNJJOHNSON & JOHNSONM Exercise/Conversion	EVP, WWC. Innovative Medicine	MExercise/Conversion	+56.5K sh	$101.87	+$5.75M	234,484.001
2025-09-04	JNJJOHNSON & JOHNSONS Sale	EVP, WWC. Innovative Medicine	SSale	−56.5K sh	$177.81	−$10M	178,013.001
2025-09-04	JNJJOHNSON & JOHNSON · Employee Stock Options (Right to Buy)M Exercise/Conversion	EVP, WWC. Innovative Medicine	MExercise/Conversion	−56.5K sh	$101.87	−$5.75M	0
2025-06-30	MCDMCDONALDS CORP · Phantom StockA Award	Director	AAward	+102.68 sh	$292.17	+$30K	2,692.43
2025-03-31	MCDMCDONALDS CORP · Phantom StockA Award	Director	AAward	+96.04 sh	$312.37	+$30K	2,676.44
2025-02-18	JNJJOHNSON & JOHNSONF Tax Payment	EVP, WWC. Innovative Medicine	FTax Payment	−651 sh	$156.15	−$102K	170,459.001
2025-02-15	JNJJOHNSON & JOHNSONM Exercise/Conversion	EVP, WWC. Innovative Medicine	MExercise/Conversion	+1,594 sh	—	—	171,110.001
2025-02-15	JNJJOHNSON & JOHNSON · Restricted Share UnitsM Exercise/Conversion	EVP, WWC. Innovative Medicine	MExercise/Conversion	−1,594 sh	—	—	3,188
2025-02-15	JNJJOHNSON & JOHNSON · Employee Stock Options (Right to Buy)A Award	EVP, WWC. Innovative Medicine	AAward	+89.8K sh	—	—	89,781
2025-02-15	JNJJOHNSON & JOHNSON · Restricted Share UnitsA Award	EVP, WWC. Innovative Medicine	AAward	+5,539 sh	—	—	5,539
2025-02-14	JNJJOHNSON & JOHNSONF Tax Payment	EVP, WWC. Innovative Medicine	FTax Payment	−410 sh	$155.26	−$63.7K	166,811.001
2025-02-14	JNJJOHNSON & JOHNSONM Exercise/Conversion	EVP, WWC. Innovative Medicine	MExercise/Conversion	+4,053 sh	—	—	170,864.001
2025-02-14	JNJJOHNSON & JOHNSONF Tax Payment	EVP, WWC. Innovative Medicine	FTax Payment	−1,348 sh	$156.71	−$211K	169,516.001
2025-02-14	JNJJOHNSON & JOHNSONM Exercise/Conversion	EVP, WWC. Innovative Medicine	MExercise/Conversion	+15.5K sh	—	—	185,924.001
2025-02-14	JNJJOHNSON & JOHNSONF Tax Payment	EVP, WWC. Innovative Medicine	FTax Payment	−7,911 sh	$156.71	−$1.24M	178,013.001
2025-02-14	JNJJOHNSON & JOHNSON · Restricted Share UnitsM Exercise/Conversion	EVP, WWC. Innovative Medicine	MExercise/Conversion	−4,053 sh	—	—	0
2025-02-14	JNJJOHNSON & JOHNSON · Performance Share UnitsM Exercise/Conversion	EVP, WWC. Innovative Medicine	MExercise/Conversion	−15.5K sh	—	—	0
2025-02-13	JNJJOHNSON & JOHNSONM Exercise/Conversion	EVP, WWC. Innovative Medicine	MExercise/Conversion	+1,302 sh	—	—	167,221.001
2025-02-13	JNJJOHNSON & JOHNSON · Restricted Share UnitsM Exercise/Conversion	EVP, WWC. Innovative Medicine	MExercise/Conversion	−1,302 sh	—	—	1,302
2025-02-10	JNJJOHNSON & JOHNSON · Performance Share UnitsA Award	EVP, WWC. Innovative Medicine	AAward	+15.5K sh	—	—	15,465
2025-02-07	JNJJOHNSON & JOHNSONM Exercise/Conversion	EVP, WWC. Innovative Medicine	MExercise/Conversion	+58.5K sh	$100.06	+$5.85M	213,355.001
2025-02-07	JNJJOHNSON & JOHNSONF Tax Payment	EVP, WWC. Innovative Medicine	FTax Payment	−47.4K sh	$153.12	−$7.26M	165,919.001
2025-02-07	JNJJOHNSON & JOHNSON · Employee Stock Options (Right to Buy)M Exercise/Conversion	EVP, WWC. Innovative Medicine	MExercise/Conversion	−58.5K sh	$100.06	−$5.85M	0
2024-12-31	MCDMCDONALDS CORP · Phantom StockA Award	Director	AAward	+700.47 sh	$289.89	+$203K	2,565.65
2024-09-30	MCDMCDONALDS CORP · Phantom StockA Award	Director	AAward	+98.52 sh	$304.51	+$30K	1,751.1
2024-06-28	MCDMCDONALDS CORP · Phantom StockA Award	Director	AAward	+117.72 sh	$254.84	+$30K	1,643.23
2024-03-29	MCDMCDONALDS CORP · Phantom StockA Award	Director	AAward	+106.4 sh	$281.95	+$30K	1,515.53

Recent filings

Accepted (ET)
Oct 24
Taubert Jennifer L0001745938-26-000005
SEC(opens sec.gov)
Aug 184
Taubert Jennifer L0000200406-26-000175
SEC(opens sec.gov)
Jul 24
Taubert Jennifer L0001745938-26-000003
SEC(opens sec.gov)
Feb 184
Taubert Jennifer L0000200406-26-000037
SEC(opens sec.gov)

Companies

Address

MCDONALD'S CORPORATION 110 NORTH CARPENTER STREET

CHICAGO, IL, 60607